Polycystic ovary syndrome and elevated body mass index independently increase type 2 diabetes risk with obesity-mediated risk dominating: a real-world data analysis of US patients.
Saved in:
| Title: | Polycystic ovary syndrome and elevated body mass index independently increase type 2 diabetes risk with obesity-mediated risk dominating: a real-world data analysis of US patients. |
|---|---|
| Authors: | Sharafutdinov K; Pharmaceuticals, Bayer AG, Research and Development, Leverkusen, Germany. Electronic address: konstantin.sharafutdinov@bayer.com., Hilpert J; Pharmaceuticals, Bayer AG, Research and Development, Berlin, Germany., Burghaus R; Pharmaceuticals, Bayer AG, Research and Development, Wuppertal, Germany., Diedrich C; Pharmaceuticals, Bayer AG, Research and Development, Leverkusen, Germany., Lippert J; Pharmaceuticals, Bayer AG, Research and Development, Wuppertal, Germany., Scheerans C; Pharmaceuticals, Bayer AG, Research and Development, Berlin, Germany., Schaper S; Pharmaceuticals, Bayer AG, Research and Development, Leverkusen, Germany. |
| Source: | Fertility and sterility [Fertil Steril] 2026 Mar; Vol. 125 (3), pp. 506-514. Date of Electronic Publication: 2025 Sep 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier for the American Society for Reproductive Medicine Country of Publication: United States NLM ID: 0372772 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-5653 (Electronic) Linking ISSN: 00150282 NLM ISO Abbreviation: Fertil Steril Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1556-5653 |
|---|---|
| DOI: | 10.1016/j.fertnstert.2025.09.013 |
